EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis

Soo-Ho Lee, Yeonghoon Son, Hyosun Jang, Hyun-Yong Kim, Kwang Seok Kim iD, Hyun-Shik Lee iD, Hae-June Lee

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27062676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Soo-Ho Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea. Hauptthemen laut MEDLINE: Fluoxetine, Alzheimer Disease, Glycogen Synthase Kinase 3 beta, Amyloid Precursor Protein Secretases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation of Korea (NRF) grant funded by the Korea government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder in the aging population. Drug repurposing provides a cost-effective strategy to identify novel therapeutics that may mitigate age-associated pathologies. Here, we report the therapeutic potential of fluoxetine, a selective serotonin reuptake inhibitor commonly used as an antidepressant, in alleviating cognitive impairment and AD-like pathology in 5xFAD mice, a transgenic model of familial AD. Chronic fluoxetine administration significantly ameliorated anxiety-like behavior and cognitive deficits in 5xFAD mice, as assessed by open field, Y-maze, and novel object recognition tests. Fluoxetine treatment was associated with reduced amyloid plaque deposition in the hippocampus and cortex, attenuation of microglial activation, and decreased expression of inflammatory cytokines. At the molecular level, fluoxetine increased phosphorylation of GSK3β at Ser9, which was associated with enhanced CREB phosphorylation and upregulation of the α-secretase ADAM10. These effects were further examined in SH-SY5Y neuronal cells, where CREB phosphorylation and ADAM10 expression were significantly modulated by GSK3β inhibition, whereas CaMKII inhibition had no detectable effect under our experimental conditions. Our findings suggest that fluoxetine modulates amyloid-associated signaling pathways in the 5xFAD model, in part through regulation of the GSK3β-CREB signaling framework. These results provide mechanistic insight into how fluoxetine may influence APP processing in an amyloid-driven pathological context, although further studies are required to clarify its translational implications in human AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineAlzheimer DiseaseGlycogen Synthase Kinase 3 betaAmyloid Precursor Protein SecretasesCyclic AMP Response Element-Binding ProteinADAM10 ProteinDrug RepositioningMembrane ProteinsAnimalsMiceHumansMice, TransgenicDisease Models, AnimalSignal TransductionPhosphorylationSelective Serotonin Reuptake Inhibitors

Stichwörter der Autor:innen

Alzheimer’s diseasecognitive impairmentfluoxetinep-CREBα-secretase

Substanzen

FluoxetineGlycogen Synthase Kinase 3 betaAmyloid Precursor Protein SecretasesCyclic AMP Response Element-Binding ProteinADAM10 ProteinMembrane ProteinsAdam10 protein, mouseSelective Serotonin Reuptake InhibitorsGsk3b protein, mouse

Autor:innen und Institutionen

  • Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Republic of Korea.
  • KNU G-LAMP Project Group, KNU Institute of Basic Sciences, School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
  • BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
  • New Drug Development Center, Osong Medical Innovation Foundation, Cheongju 28160, Republic of Korea.
  • Veterinary Medical Research Institute, College of Veterinary Medicine, Jeju National University, Jeju 63243, Republic of Korea.

ORCID-Profile: Kwang Seok Kim, Hyun-Shik Lee

Förderung

  • National Research Foundation of Korea
  • National Research Foundation of Korea (NRF) grant funded by the Korea government

Zitieren

APA

Lee, S. H., Son, Y., Jang, H., Kim, H. Y., Kim, K. S., Lee, H. S., & Lee, H. J. (2026). Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062676

Vancouver

Lee SH, Son Y, Jang H, Kim HY, Kim KS, Lee HS, et al. Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062676

BibTeX
@article{Lee2026,
  author = {Lee, Soo-Ho and Son, Yeonghoon and Jang, Hyosun and Kim, Hyun-Yong and Kim, Kwang Seok and Lee, Hyun-Shik and Lee, Hae-June},
  title = {Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27062676}
}
Kostenlos starten →